Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
Source check: Source checked. Not independent scientific confirmation.
Finding: Using gene-expression profiles from 1,447 HCC patients across TCGA, ICGC and GEO, the study quantified immune-cell signatures with ssGSEA and selected four signatures with Cox analyses and random-forest modeling to form ICSscore. The score stratified prognosis in TCGA and two independent cohorts and was associated with treatment-response datasets. These retrospective associations do not show treatment benefit.
Technology: Immune-cell signature score with Cox regression and XGBoost response classifier
Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The study built an immune-cell signature score using multivariable Cox regression and used XGBoost to classify response associations in HCC datasets; these retrospective associations do not estimate treatment effects.
- Test and result
- The ICSscore was developed from 1,447 HCC profiles and assessed for risk stratification across TCGA-LIHC and two independent cohorts; treatment-response associations were examined in HCC datasets and other cancer datasets.
- Limitation / still unknown
- The cohort and treatment-response analyses are retrospective; the reported associations do not establish prospective treatment selection or patient benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.741226/full · https://europepmc.org/article/MED/34675983 · https://pubmed.ncbi.nlm.nih.gov/34646307/
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.